Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 81 | BTSG | BRIGHTSPRING HEALTH SVCS INC | Healthcare | 50,000.0 | $2.1M | 0.26% | -148K | -74.8% | $42.61 | +33.3% |
| 82 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 28,000.0 | $1.6M | 0.20% | -111K | -79.9% | $58.15 | -31.6% |
| 83 | ALGN | ALIGN TECHNOLOGY INC | Healthcare | 7,500.0 | $1.3M | 0.16% | -92K | -92.4% | $171.43 | -13.9% |
| 84 | NVCR | NOVOCURE LTD | Healthcare | 70,000.0 | $763K | 0.09% | NEW | — | $10.90 | +53.1% |
| 85 | ATEC | ALPHATEC HLDGS INC | Healthcare | 70,000.0 | $762K | 0.09% | +50K | +250.0% | $10.88 | -6.4% |
| 86 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 115,113.0 | $609K | 0.07% | NEW | — | $5.29 | -64.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
98.9%
Technology
1.1%